More about Abcam
Abcam Plc Ord 0.2P is listed on the London Stock Exchange trading with ticker code ABC.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £236,865m, with approximately 206m shares in issue. Over the last year, Abcam share price has been traded in a range of 517, hitting a high of 1,523.00, and a low of 1,006.00.
Abcam Plc, officially known as Abcam Plc Ord 0.2P was formed in February of 1998, making the company twenty one years old. The company filed its latest accounts on 30th June 2014, showing a turnover of approximately 127.95 million GBX with gross profits of 90.39 million, or 0.4392 per issued share, and a pre-tax profit margin of 34.04%. Abcam Plc currently has 10 directors, and has had 10 previous directors over the last 21 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 27.02 million paid in salaries to the 734 staff (average wage of 37 thousand), with the directors receiving an average 185 thousand each. In the accounts filed in 2014, the company paid 14455000 in dividends, or 0.0702 per share. These accounts also showed Abcam Plc to have a net worth of 77.18 million, with 55.86 million held in cash.
Abcam is in the Medicine and Biotech Research sector.
 | James Halstead (JHD.L) |  |
 | Hikma Pharmaceuticals (HIK.L) | |
 | Genus (GNS.L) | |
 | Purecircle (PURE.L) | |
 | Greggs (GRG.L) | |
 | Clinigen (CLIN.L) | |
| Genus (GNS.L) | |
| Hikma Pharmaceuticals (HIK.L) | |
| James Halstead (JHD.L) | |
 | Glaxosmithkline (GSK.L) | |
Abcam Share Information
| Volume | 62.82k |
|---|---|
| Currency | GBX |
| Shares in Issue | 206m |
| Market Capitalisation | £236,865m |
| 52 Week High | 1,523.00 |
| 52 Week Low | 1,006.00 |